A phase III trial of nab-paclitaxel versus dacarbazine in chemotherapy-naive patients with metastatic melanoma: A subanalysis based on BRAF status

Evan Hersh, Michele Del Vecchio, Michael Paul Brown, Richard Kefford, Carmen Loquai, Alessandro Testori, Caroline Robert, Mingyu Li, Ileana Elias, Markus F. Renschler, Axel Hauschild

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)9030-9030
Number of pages1
JournalJournal of Clinical Oncology
Issue number15 supplement
Publication statusPublished - 20 May 2013
EventAnnual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States
Duration: 31 May 20134 Jun 2013

Cite this